Stanford University's SPARK Translational Research Program Pilot Grants support innovative therapeutics and diagnostics development with funding, mentorship, and industry-focused guidance.
Funder: Stanford University
Due Dates: July 27, 2026 (application opens) | Early December 2026 (oral pitch) | End of December 2026 (award notification)
Funding Amounts: $50,000 initial funding; up to $100,000 total over two years.
Summary: Supports Stanford researchers developing innovative therapeutics and diagnostics for unmet medical needs with funding, mentorship, and education.
Key Information: Requires Stanford affiliation; trainees must include eligible faculty as co-PI.
The SPARK Translational Research Program Pilot Grants at Stanford University are designed to accelerate the development of novel therapeutics and diagnostics that address significant unmet medical needs. The program combines direct funding with comprehensive mentorship and education on the product development process, leveraging the expertise of volunteer advisors from the local biotechnology sector. Projects receive guidance on intellectual property, assay development, preclinical studies, regulatory science, and commercialization strategies. The goal is to bridge the gap between academic research and clinical or commercial application, with a strong track record of moving projects into partnerships or clinical trials.